Explore how paclitaxel and innovative drug delivery systems are changing cancer treatment and improving therapeutic outcomes.

Nanoparticle-based drug delivery systems utilise the unique physicochemical properties of nanoscale carriers to enhance therapeutic efficacy whilst minimising systemic side effects. These formulations ...

Scientists engaged in precision medicine research focus intensely on target-based drug development. In doing so, they help improve the safety and efficacy profiles of future therapies by reducing ...

DDS can be based on physical mechanisms like osmosis, diffusion, erosion, dissolution, and electro-transport or biochemical methods like monoclonal antibodies, gene therapy, vector systems, ...

Engineers at Duke University have demonstrated a technique that uses microbubbles and ultrasound to help relatively large cancer drugs enter tumor cells and cause them to self-destruct. Dubbed ...

Ovarian cancer is one of the most common malignancies in women worldwide. Unlike breast cancer, ovarian cancer lacks early diagnostic markers and does not show noticeable symptoms until cancer ...

A research team led by Hong Kong Baptist University (HKBU) has developed a novel drug delivery system for Alzheimer’s disease (AD). The researchers have engineered exosomes, extracellular vesicles ...

Scientists working to enhance brain-computer interface (BCI) technology—which allows people to control devices with their thoughts—have found they can improve the performance of electrodes implanted ...

The blood–brain barrier functions as an evolutionarily optimized vascular “filter,” permitting limited penetration of small molecules like temozolomide while effectively excluding most biologics from ...

Neuroinflammation drives the progression of neurodegenerative disorders like Alzheimer's, Parkinson's, and multiple sclerosis ...